2023 Commercialization Award
Executive Vice President, Chief Scientific and Medical Officer, and President, Lilly Research Laboratories, Eli Lilly and Company
Dan Skovronsky is the chief scientific and medical officer of Eli Lilly and Company. He serves as executive vice president of science and technology and president of Lilly Research Laboratories. He also has responsibility for global business development.
Dan joined Lilly in 2010 when the company acquired Avid Radiopharmaceuticals Inc., where he had been CEO since founding the company in 2004. At Lilly, Dan has held various roles, including vice president, tailored therapeutics; vice president, diabetes research; and senior vice president, clinical and product development.
Dan completed his residency training in pathology and fellowship training in neuropathology at the Hospital of the University of Pennsylvania. He received his M.D. from the Perelman School of Medicine, University of Pennsylvania, in 2001 and his Ph.D. in neuroscience from University of Pennsylvania in 2000. Dan earned a Bachelor of Science in molecular biophysics and biochemistry from Yale University in 1994.
Nucleus Commercialization Award
Recognizes outstanding contributions to the commercialization of innovative science and technology. The awardee is a catalyst in the acceleration of technology transfer. By identifying and developing new and creative ways to transition discoveries to the marketplace, the awardee has a tangible impact on quality of life, economic development, or the welfare of society.